Delivery Order SPE2DB22D3004-SPE2DB24FRJ04
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,749.60 firm fixed price contract is for the supply of Ketorolac 30 mg/mL vials, a pain medication. The contract has a period of performance through September 16, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies for the provision of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,018.90 fixed-price contract is for the supply of Ketorolac 30 mg/mL vial, a pharmaceutical product used to treat moderate to severe pain. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. This order does not utilize a set-aside. AmerisourceBergen is a major pharmaceutical distributor that has been...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,378.40 firm-fixed-price contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/ml vials. The $1,370.88 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $4,797.29 firm-fixed-price contract is for the delivery of Ketorolac 30 mg/ml vials, a pain medication. It does not have a set-aside designation. The delivery order was awarded on August 15, 2024, with a completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ketorolac 15 mg/ml vials. The $6,080.91 firm fixed-price contract has a completion date of November 8, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.70 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 31, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vials. The contract, valued at $1,318.38, is a Firm Fixed Price Delivery Order without any set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans'...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 60 mg/2 ml vials. The contract is a Delivery Order valued at $14,133.55 and has a completion date of September 10, 2024. The contract is Firm Fixed Price and is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including...
This federal contract award, valued at $1,408.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ketorolac 15 mg/ml vial, a medication used for pain management. The contract has an ultimate completion date of June 10, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...